Abstract
Background: Polygenic risk scores for Alzheimer’s disease (AD), organized by gene networks shared between the blood and brain, may provide insights into underlying disease mechanisms common to both tissues. Methods: We derived a blood–brain network-based polygenic risk score (nbPRS) from AD-associated genetic variants for three blood-brain networks, selected by the preservation of blood and brain gene co-expression networks, and AD association. Participants from the Alzheimer’s Disease Neuroimaging Initiative (ADNI, n = 1109), Framingham Heart Study (FHS, n = 8310), the Religious Orders Study Memory Aging Project (ROSMAP, n = 1215), and Mount Sinai Brain Bank (MSBB, n = 323) were stratified into low- and high-nbPRS subgroups, then profiled using longitudinal and cross-sectional data. We compared the conversion from normal cognition to AD between nbPRS subgroups. Genes differentially expressed among low- and high-nbPRS individuals were profiled with classical neuropathological markers and we investigated potential biologically relevant pathways for the genes significantly expressed in high-risk individuals. Results: Individuals with high nbPRS in three AD-associated networks (M2, M6, M14) demonstrated significant impairment in executive function and memory performance, whereas high-risk individuals in networks M2 and M14 had significantly reduced hippocampal volume. We observed high-risk individuals in M2 and M14 developed AD at twice the rate of low-risk individuals in these networks. HLA genes were differentially expressed with transcriptome-wide significance among low- and high-nbPRS individuals in M14 and associated with neuroinflammatory and tau pathology. Conclusions: Polygenic risk scores derived from blood and brain networks can differentiate individuals with a high risk of AD conversion.
Funding Information
  • National Institute on Aging (R01-AG069453)
  • National Institute on Aging (U01-AG068057)
  • National Institute on Aging (U01-AG082665)
  • National Institute on Aging (U19-AG079774)
  • National Institute on Aging (P30-AG072978)
  • National Institute on Aging (R01-AG048927)
  • National Institute on Aging (U01-AG081230)
  • National Institute on Aging (U19-AG068753)
  • National Institute on Aging (T32GM100842)
  • National Institute on Aging (U24-AG041689-01)
  • Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago (P30-AG10161)
  • Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago (P30AG72975)
  • Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago (R01-AG15819)
  • Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago (R01-AG17917)
  • Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago (R01-AG30146)
  • Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago (R01-AG36836)
  • Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago (U01-AG32984)
  • Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago (U01-AG46152)
  • Rush Alzheimer’s Disease Center, Rush University Medical Center, Chicago (U01-AG61358)
  • Translational Genomics Research Institute
  • Illinois Department of Public Health
  • Translational Genomics Research Institut
  • Alzheimer's Disease Neuroimaging Initiative (U01 AG024904)
  • Alzheimer's Disease Neuroimaging Initiative (W81XWH-12-2-0012)

This publication has 64 references indexed in Scilit: